These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22188258)

  • 1. Silodosin and its potential for treating premature ejaculation: a preliminary report.
    Sato Y; Tanda H; Nakajima H; Nitta T; Akagashi K; Hanzawa T; Tobe M; Haga K; Uchida K; Honma I
    Int J Urol; 2012 Mar; 19(3):268-72. PubMed ID: 22188258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silodosin versus naftopidil in the treatment of premature ejaculation: A prospective multicenter trial.
    Sato Y; Otani T; Amano T; Araki T; Kondou N; Matsukawa M; Tobe M; Haga K; Uchida K; Honma I
    Int J Urol; 2017 Aug; 24(8):626-631. PubMed ID: 28627033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silodosin in the management of lower urinary tract symptoms as a result of benign prostatic hyperplasia: who are the best candidates.
    Capitanio U; Salonia A; Briganti A; Montorsi F
    Int J Clin Pract; 2013 Jun; 67(6):544-51. PubMed ID: 23409749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silodosin improved spontaneous ejaculation induced by mental strain.
    Sato Y
    Int J Urol; 2014 Aug; 21(8):841. PubMed ID: 24650209
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of Seminal emission is the main cause of anejaculation induced by a new highly selective alpha1A-blocker in normal volunteers.
    Kobayashi K; Masumori N; Hisasue S; Kato R; Hashimoto K; Itoh N; Tsukamoto T
    J Sex Med; 2008 Sep; 5(9):2185-90. PubMed ID: 18399947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double-blind, placebo-controlled study.
    Dinsmore WW; Wyllie MG
    BJU Int; 2009 Apr; 103(7):940-9. PubMed ID: 19245438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of silodosin on sexual function - realistic picture from the everyday clinical practice.
    Capogrosso P; Serino A; Ventimiglia E; Boeri L; Dehò F; Damiano R; Briganti A; Montorsi F; Salonia A
    Andrology; 2015 Nov; 3(6):1076-81. PubMed ID: 26446512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silodosin causes impaired ejaculation and enlargement of seminal vesicles in sexually active men treated for lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Bozkurt O; Demir O; Sen V; Esen A
    Urology; 2015 May; 85(5):1085-1089. PubMed ID: 25744372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-analysis of efficacy and safety of the new α1A-adrenoceptor-selective antagonist silodosin for treating lower urinary tract symptoms associated with BPH.
    Wu YJ; Dong Q; Liu LR; Wei Q
    Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):79-84. PubMed ID: 22986578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silodosin, a new alpha1A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo-controlled, double-blind study in Japanese men.
    Kawabe K; Yoshida M; Homma Y;
    BJU Int; 2006 Nov; 98(5):1019-24. PubMed ID: 16945121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orgasm is preserved regardless of ejaculatory dysfunction with selective alpha1A-blocker administration.
    Kobayashi K; Masumori N; Kato R; Hisasue S; Furuya R; Tsukamoto T
    Int J Impot Res; 2009; 21(5):306-10. PubMed ID: 19536124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid efficacy of the highly selective alpha1A-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia: pooled results of 2 phase 3 studies.
    Marks LS; Gittelman MC; Hill LA; Volinn W; Hoel G
    J Urol; 2009 Jun; 181(6):2634-40. PubMed ID: 19371887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid efficacy of the highly selective α(1A)-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia: pooled results of 2 phase 3 studies.
    Marks LS; Gittelman MC; Hill LA; Volinn W; Hoel G
    J Urol; 2013 Jan; 189(1 Suppl):S122-8. PubMed ID: 23234617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe.
    Chapple CR; Montorsi F; Tammela TL; Wirth M; Koldewijn E; Fernández Fernández E;
    Eur Urol; 2011 Mar; 59(3):342-52. PubMed ID: 21109344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short- and long-term effects of silodosin, a selective alpha 1A-adrenoceptor antagonist, on ejaculatory function in rats.
    Yono M; Yamamoto Y; Imanishi A; Fukagawa A; Latifpour J; Yoshida M
    BJU Int; 2009 Jun; 103(12):1680-5. PubMed ID: 19220259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of dry ejaculation caused by highly selective alpha1A-blocker: randomized, double-blind, placebo-controlled crossover pilot study in healthy volunteer men.
    Shimizu F; Taguri M; Harada Y; Matsuyama Y; Sase K; Fujime M
    J Sex Med; 2010 Mar; 7(3):1277-83. PubMed ID: 20102447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New clinical evidence of silodosin, an α(1A) selective adrenoceptor antagonist, in the treatment for lower urinary tract symptoms.
    Yoshida M; Kudoh J; Homma Y; Kawabe K
    Int J Urol; 2012 Apr; 19(4):306-16. PubMed ID: 22251148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of premature ejaculation with paroxetine hydrochloride as needed: 2 single-blind placebo controlled crossover studies.
    McMahon CG; Touma K
    J Urol; 1999 Jun; 161(6):1826-30. PubMed ID: 10332446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing Aspects of Male Sexual Functions Accompanying Treatment of Benign Prostatic Hyperplasia With Silodosin 8 mg Per Day.
    ; Cihan A; Kazaz İO; Yıldırım Ö; Deliktaş H; Ongün Ş; Gül Ü; Şahin B; Üre İ; Özkara H
    J Sex Med; 2020 Jun; 17(6):1094-1100. PubMed ID: 32217036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of three types of alpha-1 adrenoceptor blocker on lower urinary tract symptoms and sexual function in males with benign prostatic hyperplasia.
    Yokoyama T; Hara R; Fukumoto K; Fujii T; Jo Y; Miyaji Y; Nagai A; Sone A
    Int J Urol; 2011 Mar; 18(3):225-30. PubMed ID: 21272091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.